Cargando…

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy

BACKGROUND: We aimed to study the predictive value of combined 18F-fluoro-deoxy-D-glucose positron emission tomography and computerized tomography (FDG-PET-CT), on outcomes in locally advanced pancreatic carcinoma (LAPC) patients treated with concurrent chemoradiotherapy (C-CRT). METHODS: Thirty-two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Topkan, Erkan, Parlak, Cem, Kotek, Ayşe, Yapar, Ali Fuat, Pehlivan, Berrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224773/ https://www.ncbi.nlm.nih.gov/pubmed/22074002 http://dx.doi.org/10.1186/1471-230X-11-123

Ejemplares similares

FDG-PET/CT–based restaging may alter initial management decisions and clinical outcomes in patients with locally advanced pancreatic carcinoma planned to undergo chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2013)

Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
por: Topkan, Erkan, et al.
Publicado: (2012)

Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy
por: Parlak, Cem, et al.
Publicado: (2012)

Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas
por: Topkan, Erkan, et al.
Publicado: (2022)

The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2021)

The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
por: Yilmaz, Busra, et al.
Publicado: (2023)

Bilateral glomus tumor treated with PET-CT based conformal radiotherapy: a case report
por: Onal, Cem, et al.
Publicado: (2009)

Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinoma
por: Topkan, Erkan, et al.
Publicado: (2008)

Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2020)

Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2020)

The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
por: Kucuk, Ahmet, et al.
Publicado: (2020)

The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2023)

High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients
por: Kucuk, Ahmet, et al.
Publicado: (2022)

Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy
por: Onal, Cem, et al.
Publicado: (2021)

A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer
por: Kucuk, Ahmet, et al.
Publicado: (2023)

Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide
por: Topkan, Erkan, et al.
Publicado: (2020)

Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients
por: Topkan, Erkan, et al.
Publicado: (2018)

Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide
por: Topkan, Erkan, et al.
Publicado: (2020)

Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study
por: Topkan, Erkan, et al.
Publicado: (2020)

Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy
por: Pehlivan, Umur Anil, et al.
Publicado: (2023)

Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma
por: Pehlivan, Berrin, et al.
Publicado: (2009)

Sarcomatoid Carcinoma of the Urinary Bladder Treated with Adjuvant Radiotherapy: A Case Report
por: Onal, Cem, et al.
Publicado: (2009)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2008)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer
por: Atsumi, Kazushige, et al.
Publicado: (2013)

Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer
por: Kwak, Yoo-Kang, et al.
Publicado: (2014)

Letter to the Editor: Radiotherapy Increases aMMP-8 Levels and Neutrophil/Lymphocyte Ratio Rapidly in Head and Neck Cancer Patients: A Pilot Study
por: Yilmaz, Busra, et al.
Publicado: (2023)

In reply to Cheng et al. (DOI: 10.1186/s13550-023-00965-8)
por: Somay, Efsun, et al.
Publicado: (2023)

Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses
por: Onal, Cem, et al.
Publicado: (2009)

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

Valero’s host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients
por: Topkan, Erkan, et al.
Publicado: (2023)

Pretreatment Photopenia on (18)F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2020)

Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers
por: Topkan, Erkan, et al.
Publicado: (2022)

(18)F-FDG PET/CT Imaging in an Unusual Case of Cutaneous Melanoma Arising From Congenital Melanocytic Nevus in a Two-year-old Girl
por: Erhamamcı, Seval, et al.
Publicado: (2021)

Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
por: Yilmaz, Busra, et al.
Publicado: (2021)

Value of (18)F-FDG PET/CT for Assessment of Advanced Lacrimal Sac Non-Keratinizing Squamous Cell Carcinoma Successfully Treated with Concurrent Chemoradiotherapy
por: Liao, Ching-Yu, et al.
Publicado: (2021)

Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors
por: Topkan, Erkan, et al.
Publicado: (2023)

Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013)

The Prognostic Value of Sequential (18) F-FDG PET/CT Metabolic Parameters in Outcomes of Upper-Third Esophageal Squamous Cell Carcinoma Patients Treated with Definitive Chemoradiotherapy
por: Ha, Le Ngoc, et al.
Publicado: (2023)

Dosimetric Comparison of Lung-Sparing Radiation Therapy between Volumetric Arc Therapy and Helical Tomotherapy for Unresectable Malignant Pleural Mesothelioma
por: Pehlivan, Berrin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kcab3g2s8cqiu6vr0lev7fls0v